BB's Stock Haven

[TraderTamara]

INO Inovio Pharma

note that the funding for these trials comes heavily from the sponsoring institutions, leaving Inovio with $0 in overall debt.

Third-party funding includes:

Bill and Melinda Gates are funding the preclinical development of Syncon synthetic vaccine for malaria

The HIV Vaccine Trial Network is providing $23.5 million in funding for Pennvax-B

The U.S. Military HIV Research Program (MHRP) is sponsoring Pennvax-G

The US Department of Homeland Security towards a Syncon vaccine for foot & mouth disease.

National Cancer Institute

Merck pharmaceuticals

Also the 2013 Vaccine Industry Excellence (ViE) award winner for "Best Therapeutic Vaccine" and "Best Early Stage Biotech" at the World Vaccine Congress

At around .70 pennies you can't go wrong imo